Charles A. Reinhart, III
Overview
Charles A. Reinhart, III received an average of $2M in total compensation, including $409K in salary, at Pacira Pharmaceuticals from 2016 to 2021.
2021Pacira PharmaceuticalsChief Financial Officer
2020Pacira PharmaceuticalsChief Financial Officer
2019Pacira PharmaceuticalsChief Financial Officer
2018Pacira PharmaceuticalsChief Financial Officer
2017Pacira PharmaceuticalsChief Financial Officer
2016Pacira PharmaceuticalsChief Financial Officer
Source: SEC filings on April 22, 2022, April 24, 2020, April 22, 2019, April 27, 2018, and April 21, 2017.
Related executives
We found 14 more executives who work or worked at Pacira Pharmaceuticals.
David Stack
Pacira Pharmaceuticals
Chief Executive Officer
Roy Winston
Pacira Pharmaceuticals
Chief Medical Officer
Jonathan Slonin
Pacira Pharmaceuticals
Chief Clinical Officer
Max Reinhardt
Pacira Pharmaceuticals
President, Rest of World
Kristen Williams
Pacira Pharmaceuticals
Chief Administrative Officer
Dennis McLoughlin
Pacira Pharmaceuticals
Chief Commercial Officer
Richard Scranton
Pacira Pharmaceuticals
Chief Medical Officer
Scott Braunstein
Pacira Pharmaceuticals